Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Experimental and molecular pathology (Print)

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.yexmp.2015.06.015PMID 26112094
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH

  2015cited by this paper
• Macrophages, immunity, and metabolic disease.

  2014cited by this paper
• Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice

  2014cited by this paper
• Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH

  2014cited by this paper
• Infiltrating Monocyte-Derived Macrophages and Resident Kupffer Cells Display Different Ontogeny and Functions in Acute Liver Injury

  2014cited by this paper
• Pathological features of fatty liver disease.

  2014cited by this paper
• M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease

  2014cited by this paper
• Macrophage heterogeneity in liver injury and fibrosis.

  2014cited by this paper
• Resolution of inflammation: an integrated view

  2013cited by this paper
• Hepatic Crown-Like Structure: A Unique Histological Feature in Non-Alcoholic Steatohepatitis in Mice and Humans

  2013cited by this paper
• Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis

  2013cited by this paper
• Phenotypic polarization of macrophages in atherosclerosis.

  2013cited by this paper
• Hanging in the balance: endogenous anti‐inflammatory mechanisms in tissue repair and fibrosis

  2013cited by this paper
• Ligand-specific conformational change of the G-protein–coupled receptor ALX/FPR2 determines proresolving functional responses

  2013cited by this paper
• Adipose tissue foam cells are present in human obesity.

  2013cited by this paper
• Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis[S]

  2013cited by this paper
• Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease.

  2013cited by this paper
• Adiponectin: key player in the adipose tissue-liver crosstalk.

  2012cited by this paper
• Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.

  2012cited by this paper
• Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients.

  2012cited by this paper
• Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis.

  2012cited by this paper
• Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice.

  2012cited by this paper
• Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production*

  2012cited by this paper
• Functional Role of Monocytes and Macrophages for the Inflammatory Response in Acute Liver Injury

  2012cited by this paper
• Endoplasmic Reticulum Stress and the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease

  2011cited by this paper
• Protective and pathogenic functions of macrophage subsets

  2011cited by this paper
• Differential Lipid Partitioning Between Adipocytes and Tissue Macrophages Modulates Macrophage Lipotoxicity and M2/M1 Polarization in Obese Mice

  2011cited by this paper
• Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury

  2011cited by this paper
• Gastrointestinal , Hepatobiliary and Pancreatic Pathology Increased Hepatic Myeloperoxidase Activity in Obese Subjects with Nonalcoholic Steatohepatitis

  2009cited by this paper
• Annexin A1 and glucocorticoids as effectors of the resolution of inflammation

  2009cited by this paper
• Isolation of Liver Kupffer Cells

  2002cited by this paper
• Isolation of Mouse Intrahepatic Lymphocytes

  1997cited by this paper
• Nonalcoholic fatty liver disease.

  1986cited by this paper

• Single-Cell RNA Sequencing Reveals Macrophage Dynamics During MASH in Leptin-Deficient Rats

  2025cites this paper
• Immune activation induced by dysregulated lipid metabolism in the pathogenesis of type 2 diabetes

  2025cites this paper
• Formylpeptide receptors: A novel target to treat cardiometabolic complications.

  2025cites this paper
• Proteomics and cytokine array jointly reveal the role of macrophage proinflammatory shift in liver fibrosis in dairy cows with ketosis

  2025cites this paper
• Diverse Functions of Macrophages in Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease: Bridging Inflammation and Metabolism

  2025cites this paper
• Immune Checkpoints and the Immunology of Liver Fibrosis

  2025cites this paper
• Ex-vivo expanded CD34+ cell transplantation alleviates fibrotic liver injury via innate immune modulation in metabolic dysfunction-associated steatohepatitis mice.

  2024cites this paper
• A cyclic peptide-grafted Fc with hepatocyte growth factor functionality ameliorates hepatic fibrosis in a non-alcoholic steatohepatitis mouse model

  2024cites this paper
• Impacts of liver macrophages, gut microbiota, and bile acid metabolism on the differences in iHFC diet-induced MASH progression between TSNO and TSOD mice

  2024cites this paper
• Chronic Liver Disease and Promising Therapeutic Strategy: A Concise Review

  2024cites this paper
• Myeloid-specific fatty acid transport protein 4 deficiency induces a sex-dimorphic susceptibility for nonalcoholic steatohepatitis in mice fed a high-fat, high-cholesterol diet

  2023cites this paper
• Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis

  2023cites this paper
• Efferocytosis in liver disease

  2023cites this paper
• Dynamics of Liver Macrophage Subsets in a Novel Mouse Model of Non-Alcoholic Steatohepatitis Using C57BL/6 Mice

  2023cites this paper
• Efferocytosis: An Emerging Therapeutic Strategy for Type 2 Diabetes Mellitus and Diabetes Complications

  2023cites this paper
• Macrophages and the development and progression of non-alcoholic fatty liver disease

  2023cites this paper
• The Multifaceted Roles of Macrophages in NAFLD Pathogenesis

  2023cites this paper
• Claspin haploinsufficiency leads to defects in fertility, hyperplasia and an increased oncogenic potential

  2022cites this paper
• Single-cell transcriptome landscape of zebrafish liver reveals hepatocytes and immune cell interactions in understanding nonalcoholic fatty liver disease

  2022cites this paper
• Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis (NASH).

  2022cites this paper
• Design and Evaluation of Autophagy-Inducing Particles for the Treatment of Abnormal Lipid Accumulation

  2022cites this paper
• Metabolic dysfunction‐associated fatty liver disease directly related to liver fibrosis independent of insulin resistance, hyperlipidemia, and alcohol intake in morbidly obese patients

  2022cites this paper
• Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonist

  2022cites this paper
• Oxidative stress in nonalcoholic fatty liver disease: a reappraisal of the role in supporting inflammatory mechanisms

  2022cites this paper
• Proton pump inhibitors display anti‐tumour potential in glioma

  2022cites this paper
• Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2/NQO-1 pathway.

  2022cites this paper
• Deleting Gata4 in hepatocytes promoted the progression of NAFLD via increasing steatosis and apoptosis, and desensitizing insulin signaling.

  2022cites this paper
• Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease

  2022cites this paper
• Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease

  2022cites this paper
• Osr1 Regulates Macrophage-mediated Liver Inflammation in Nonalcoholic Fatty Liver Disease Progression

  2022cites this paper
• The ménage à trois of autophagy, lipid droplets and liver disease

  2021cites this paper
• Hepatic Macrophage as a Key Player in Fatty Liver Disease

  2021cites this paper
• TNF-Like Ligand 1 Aberrance Aggravates Nonalcoholic Steatohepatitis via M1 Macrophage Polarization

  2021cites this paper
• Visfatin exacerbates hepatic inflammation and fibrosis in a methionine‐choline‐deficient diet mouse model

  2021cites this paper
• Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors

  2020cites this paper
• Macrophages in metabolic associated fatty liver disease

  2020cites this paper
• Mechanisms of Fibrosis Development in NASH.

  2020cites this paper
• Splenectomy Promotes Macrophage Polarization in a Mouse Model of Concanavalin A- (ConA-) Induced Liver Fibrosis

  2019cites this paper
• Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues.

  2019cites this paper
• Cigarette smoking differentially regulates inflammatory responses in a mouse model of nonalcoholic steatohepatitis depending on exposure time point.

  2019cites this paper
• Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo.

  2019cites this paper
• Increased Levels of Txa2 Induced by Dengue Virus Infection in IgM Positive Individuals Is Related to the Mild Symptoms of Dengue

  2018cites this paper
• The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

  2018cites this paper
• In vitro distinction between proinflammatory and antiinflammatory macrophages with gadolinium‐liposomes and ultrasmall superparamagnetic iron oxide particles at 3.0T

  2018cites this paper
• A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.

  2017cites this paper
• Targeting hepatic macrophages to treat liver diseases.

  2017cites this paper
• Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice

  2017cites this paper
• A novel glucagon‐like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice

  2017cites this paper
• Niacin and olive oil promote skewing to the M2 phenotype in bone marrow-derived macrophages of mice with metabolic syndrome.

  2016cites this paper
• Innate Immunity and Inflammation in NAFLD/NASH

  2016cites this paper
• Activation and increase of radio-sensitive CD11b+ recruited Kupffer cells/macrophages in diet-induced steatohepatitis in FGF5 deficient mice

  2016cites this paper
• Kupffer Cells Undergo Fundamental Changes during the Development of Experimental NASH and Are Critical in Initiating Liver Damage and Inflammation

  2016cites this paper
• Tetradecylthiopropionic acid induces hepatic mitochondrial dysfunction and steatosis, accompanied by increased plasma homocysteine in mice

  2016cites this paper
• World Journal of Diabetes

  year unknowncites this paper